严重钝性创伤的CT优先复苏:倾向性评分匹配队列研究
这项回顾性队列研究(2019-2023)在单中心将接受CTFR的成人钝性创伤患者与日本创伤数据库患者进行1:1倾向性评分匹配(每组n=248),比较输血、至止血干预时间及死亡率。CTFR缩短了至CT启动时间(中位数0.4 vs 29.0分钟)和至首次止血干预时间(中位数53.7 vs 134.0分钟),24小时内任何红细胞输注比例相似(29.4% vs 30.6%),但校正后24小时红细胞输注量更低(平均差-0.84单位;95%CI:-1.65至-0.03),院内死亡率相似(9.7% vs 8.9%)。在表现为休克的探索性亚组中,CTFR与更大的24小时红细胞输注量降低相关(校正平均差-3.76单位;95%CI:-6.44至-1.09)。
要点
- 在匹配的成人钝性创伤患者中,CTFR组至CT启动时间中位数0.4分钟,对照组29.0分钟(p<0.001)。
- CTFR组至首次止血干预时间中位数53.7分钟,对照组134.0分钟(p<0.001)。
- 校正后24小时红细胞输注量CTFR组更低(平均差-0.84单位;95%CI:-1.65至-0.03;p=0.043),但24小时内任何红细胞输注比例相似(29.4% vs 30.6%;p=0.845)。
- 院内死亡率CTFR组9.7%,对照组8.9%(p=0.877),无显著差异。
- 休克亚组中CTFR与更大的24小时红细胞输注量降低相关(校正平均差-3.76单位;95%CI:-6.44至-1.09;p=0.006),为探索性分析。
适用人群与场景
- 成人钝性创伤患者,在配备CT的创伤复苏室内接受CTFR(立即全身CT并预设止血干预触发条件)者,与日本创伤数据库全国登记队列中接受常规处理者进行比较。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- CTFR策略为在配备CT的创伤复苏室内立即行全身CT,并预设止血干预触发条件;原文未提及具体药物剂量、给药途径或目标值。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:回顾性队列研究,单中心CTFR组与日本创伤数据库全国登记队列比较,1:1倾向性评分匹配,每组n=248。
- 主要终点:24小时红细胞输注单位数,CTFR组校正后平均差-0.84单位(95%CI:-1.65至-0.03;p=0.043)。
- 关键次要终点:至CT启动时间中位数0.4 vs 29.0分钟(p<0.001);至首次止血干预时间中位数53.7 vs 134.0分钟(p<0.001);24小时内任何红细胞输注比例29.4% vs 30.6%(p=0.845);院内死亡率9.7% vs 8.9%(p=0.877)。
- 探索性休克亚组:CTFR与更大的24小时红细胞输注量降低相关(校正平均差-3.76单位;95%CI:-6.44至-1.09;p=0.006)。
- 敏感性分析采用多重插补。
证据类型、等级与局限
- 证据类型:回顾性队列研究;证据等级:Level III(治疗/管理)。
- 局限:单中心CTFR组与全国登记队列比较,非随机化,可能存在残余混杂;休克亚组为探索性分析;原文未提及其他局限。
对床旁实践的改变
- 对于成人严重钝性创伤,在配备CT的复苏室内采用CTFR策略可缩短至CT启动和至止血干预的时间,并可能轻度降低24小时红细胞输注量,尤其对表现为休克的患者可能更明显;但死亡率无差异,需注意此为回顾性队列研究的关联性结果。
- 原文未提及适用与不适用人群的具体标准,临床决策应结合实际情况。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In unstable blunt trauma, whole-body computed tomography (WBCT) is often deferred because the bleeding source is uncertain, potentially delaying definitive hemorrhage control. This retrospective cohort study assessed whether CT-first resuscitation (CTFR)-immediate WBCT in a CT-equipped trauma resuscitation room with prespecified triggers for hemorrhage control-is associated with transfusion, time to hemostatic intervention, and mortality after blunt trauma.
METHODS: We conducted a retrospective cohort study (2019-2023) comparing adults managed with CTFR at a single center with patients in the Japan Trauma Data Bank, a national trauma registry. We performed 1:1 propensity score matching (n = 248 per group). The primary outcome was 24-hour red blood cell (RBC) units; secondary outcomes were time to CT initiation, time to first hemostatic intervention (surgical or endovascular), and in-hospital mortality. Sensitivity analyses used multiple imputation.
RESULTS: CTFR shortened the time to CT initiation (median, 0.4 vs. 29.0 min; p<0.001) and time to first hemostatic intervention (median, 53.7 vs. 134.0 min; p<0.001). Any RBC transfusion within 24 hours was similar (29.4% vs. 30.6%; p = 0.845). Adjusted 24-hour RBC units were lower with CTFR (mean difference, -0.84 units; 95% CI: -1.65 to -0.03; p = 0.043). In-hospital mortality was similar (9.7% vs. 8.9%; p=0.877). In an exploratory subgroup of patients presenting with shock, CTFR was associated with a larger reduction in 24-hour RBC units (adjusted mean difference, -3.76 units; 95% CI: -6.44 to -1.09; p = 0.006).
CONCLUSIONS: In a matched comparison with a national registry cohort, CTFR was associated with earlier WBCT, shorter time to hemostatic intervention, and modestly lower adjusted 24-hour RBC transfusion requirements, while mortality was similar. These associations appeared more pronounced among patients presenting with shock in exploratory subgroup analyses. (J Trauma Acute Care Surg 2026;00:000-000. Copyright © 2026 Wolters Kluwer Health, Inc. All rights reserved.).
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.
参考来源
- Matsumoto S, Senoo S, Aoki M, et al. CT-first resuscitation for severe blunt trauma: A propensity score-matched cohort study. J Trauma Acute Care Surg. 2026. PMID: 42385208. doi:10.1097/TA.0000000000005105
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。